TRANPAS - TReating Anorexia Nervosa Plus Autism Spectrum
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25+
SponsorGöteborg University
About this trial
In a pilot study, the investigators will validate a so-called autism care location in an inpatient ward. The care location will be adapted for patients with anorexia nervosa (AN) and concurrent autism (AN+autism). In order to investigate the effect of a tailored care location for patients with AN + autism, the evaluation will include weight development and changes in nutritional intake, eating disorder and anxiety symptoms. The overall aim is to improve treatment for this specific AN subgroup, that otherwise has a worse prognosis regarding AN recovery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
25 years or older
Meeting criteria for both anorexia nervosa and autism spectrum disorder according to the DSM-5
In need of inpatient care due to anorexia nervosa
Disqualifiers
24 years or younger
Not in need of inpatient care due to anorexia nervosa
Not meeting criteria for both anorexia nervosa and autism spectrum disorder according to the DSM-5
Trial design
Design model
Single group
Treatments tested in this trial
Anorexia nervosa plus autism
Other interventionIn the inpatient care the treatment model takes into account the patient's perception disorders, meaning e.g. an adapted mealtime situation where the patient can eat separately or wear hearing protection if necessary. The patients have an adapted meal plan regarding difficulties with specific textures or foods. To meet their need for continuity, they have the same contact persons throughout the entire period of care. The healthcare staff receive training in working with the specific subgroup and have regular exchanges of experience regarding the patient group, 15 minutes every or every two weeks.
Treatment groups
10 Participants
are divided into 1 treatment groupGroup A: Anorexia nervosa plus autismOther 1 intervention
Trial outcomes
Primary outcomes
1
BMI change between baseline and discharge 12 weeks later
Body Mass Index: weight (kilograms)/height (meters)2
Time frame
At admission, at discharge 12 weeks later, and 6 months after dischargeSecondary outcomes
1
Change of level of anxiety between baseline and discharge 12 weeks later
Anxiety assessed using General Anxiety Disorder 7-item (GAD-7)
Time frame
At admission, at discharge 12 weeks later, and 6 months after discharge2
Change of Quality of life between baseline and discharge 12 weeks later
Quality of life (QoL) assessed using Short Form Health Survey (SF-36)
Time frame
At admission, at discharge 12 weeks later, and 6 months after dischargeLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: